Rezolute

This study tests a new drug called ersodetug for people whose tumors cause dangerously low blood sugar that standard treatments can't control. About 16 adults will receive the drug alongside their usual care to see if it reduces or eliminates the need for IV glucose. The goal is …

This program offers an experimental drug, ersodetug, to people with severe low blood sugar caused by certain tumors, when standard treatments don't work. It is for those who cannot join a formal clinical trial. The goal is to help control blood sugar levels and manage symptoms.